CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findings A follow-up Phase 3 study will be discussed with regulatory authorities PLD is ...

Liver cysts were found in over 80% of patients with ADPKD but were not associated with chronic kidney disease stage, Mayo classification, PKD1 or PKD2 genotype variant, liver enzyme levels, or quality ...

Credit: Getty Images The inaugural ADPKD guideline introduces new ADPKD nomenclature and offers updated recommendations on therapies to slow disease progression. The inaugural ADPKD guideline from ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...

Liver disease includes any condition that damages your liver. Over time, scar tissue can build up in your liver. Scarring or fibrosis can progress over many years until you develop cirrhosis—the most ...

WASHINGTON -- Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic dysfunction-associated steatotic liver disease (MASLD) and polycystic ovary ...